Curative Ventures V LLC
Follow13F filer, CIK 1754072, Dallas, TX
Curative Ventures V LLC reported $14,603,341 across 1 holding for the quarter ended 2026-06-30, in a 13F-HR filed 2026-07-31.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-26-327493
- Period
- 2026-06-30
- Reported value
- $14.6M
- Holdings
- 1
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Holdings, Q2 2026
Share positions as resolved from 13F-HR 0001193125-26-327493, largest first. % of portfolio is the value over $14,603,341, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| Instil Bio, Inc.Instil Bio, Inc. | 1,899,004 | $14.6M | 100% | 0 |
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001193125-26-327493 | base | 2026-07-31 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001193125-26-327493 | Quarter ended 2026-06-30 | 2026-07-31 | acceptance time not in the bulk data set | |
| 13F-HR 0001193125-26-190600 | Quarter ended 2026-03-31 | 2026-04-29 | acceptance time not in the bulk data set | |
| 13F-HR 0001193125-26-034909 | Quarter ended 2025-12-31 | 2026-02-03 | acceptance time not in the bulk data set | |
| 13F-HR 0001193125-25-262215 | Quarter ended 2025-09-30 | 2025-11-03 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-25-006728 | Quarter ended 2025-06-30 | 2025-07-29 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-25-003903 | Quarter ended 2025-03-31 | 2025-04-30 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-25-000699 | Quarter ended 2024-12-31 | 2025-01-29 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-24-010142 | Quarter ended 2024-09-30 | 2024-10-31 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-24-006614 | Quarter ended 2024-06-30 | 2024-07-17 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-24-004071 | Quarter ended 2024-03-31 | 2024-05-08 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-24-001408 | Quarter ended 2023-12-31 | 2024-02-12 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-23-010059 | Quarter ended 2023-09-30 | 2023-11-13 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-23-006578 | Quarter ended 2023-06-30 | 2023-08-02 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-23-003978 | Quarter ended 2023-03-31 | 2023-05-08 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-23-000449 | Quarter ended 2022-12-31 | 2023-01-30 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-22-011416 | Quarter ended 2022-09-30 | 2022-11-10 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-22-007756 | Quarter ended 2022-06-30 | 2022-08-04 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-22-005652 | Quarter ended 2022-03-31 | 2022-05-13 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-22-002642 | Quarter ended 2021-12-31 | 2022-02-14 | acceptance time not in the bulk data set |